MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases

Ludwig, Stephan; Pleschka, Stephan; Planz, Oliver

dc.contributor.author	Planz, Oliver
dc.date.accessioned	2023-08-28T06:06:37Z
dc.date.available	2023-08-28T06:06:37Z
dc.date.issued	2023
dc.identifier.issn	1879-6257
dc.identifier.uri	http://hdl.handle.net/10900/145009
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.coviro.2023.101304	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230619000000_01044
utue.personen.roh	Ludwig, Stephan
utue.personen.roh	Pleschka, Stephan
utue.personen.roh	Planz, Oliver
dcterms.isPartOf.ZSTitelID	Current Opinion in Virology	de_DE
dcterms.isPartOf.ZS-Issue	Article 101304	de_DE
dcterms.isPartOf.ZS-Volume	59	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE